The Journal of Urology
Volume 178, Issue 4 , Pages 1150-1156, October 2007

Application of Artificial Intelligence to the Management of Urological Cancer

  • Maysam F. Abbod

      Affiliations

    • School of Engineering and Design, Brunel University, West London, United Kingdom
    • Equal study contribution.
  • ,
  • James W.F. Catto

      Affiliations

    • Academic Urology Unit, University of Sheffield, Sheffield, United Kingdom
    • Equal study contribution.
  • ,
  • Derek A. Linkens

      Affiliations

    • Department of Automatic Control and Systems Engineering, University of Sheffield, Sheffield, United Kingdom
  • ,
  • Freddie C. Hamdy

      Affiliations

    • Academic Urology Unit, University of Sheffield, Sheffield, United Kingdom
    • Corresponding Author InformationCorrespondence: Academic Urology Unit, K Floor, Royal Hallamshire Hospital, Glossop Rd., Sheffield, S10 2JF, United Kingdom (telephone: +44 +114 271 2154; FAX: +44 +114 271 2268).

Received 13 October 2006 published online 15 August 2007.

Purpose

Artificial intelligence techniques, such as artificial neural networks, Bayesian belief networks and neuro-fuzzy modeling systems, are complex mathematical models based on the human neuronal structure and thinking. Such tools are capable of generating data driven models of biological systems without making assumptions based on statistical distributions. A large amount of study has been reported of the use of artificial intelligence in urology. We reviewed the basic concepts behind artificial intelligence techniques and explored the applications of this new dynamic technology in various aspects of urological cancer management.

Materials and Methods

A detailed and systematic review of the literature was performed using the MEDLINE® and Inspec® databases to discover reports using artificial intelligence in urological cancer.

Results

The characteristics of machine learning and their implementation were described and reports of artificial intelligence use in urological cancer were reviewed. While most researchers in this field were found to focus on artificial neural networks to improve the diagnosis, staging and prognostic prediction of urological cancers, some groups are exploring other techniques, such as expert systems and neuro-fuzzy modeling systems.

Conclusions

Compared to traditional regression statistics artificial intelligence methods appear to be accurate and more explorative for analyzing large data cohorts. Furthermore, they allow individualized prediction of disease behavior. Each artificial intelligence method has characteristics that make it suitable for different tasks. The lack of transparency of artificial neural networks hinders global scientific community acceptance of this method but this can be overcome by neuro-fuzzy modeling systems.

Key Words: bladder, bladder neoplasms, prostate, prostatic neoplasms, neural networks (computer)

Abbreviations and Acronyms: AI, artificial intelligence, ANFIS, adaptive neuro-fuzzy inference system, ANN, artificial neural network, CaP, prostatic carcinoma, DSS, decision support system, LR, logistic regression, MLP, multilayer perceptron, NFM, neuro-fuzzy logic modeling system, PSA, prostate specific antigen, UC, urothelial cancer

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Supported by a Medical Research Council fellowship, a British Urological Foundation/Merck Sharpe and Dohme scholarship, and a GlaxoSmithKline Clinician Scientist award (JWFC).

PII: S0022-5347(07)01393-6

doi:10.1016/j.juro.2007.05.122

The Journal of Urology
Volume 178, Issue 4 , Pages 1150-1156, October 2007